Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cellsin vivo
Authors:
- 28 February 2007
- journal article
- research article
- Published by Wiley in Developmental Neurobiology
- Vol. 67 (7) , 884-894
Abstract
Glaucoma is a major cause of vision impairment, which arises from the sustained and progressive apoptosis of retinal ganglion cells (RGC), with ocular hypertension being a major risk or co‐morbidity factor. Because RGC death often continues after normalization of ocular hypertension, growth factor‐mediated protection of compromised neurons may be useful. However, the therapeutic use of nerve growth factor (NGF) has not proven effective at delaying RGC death in glaucoma. We postulated that one cause for the failure of NGF may be related to its binding to two receptors, TrkA and p75. These receptors have distinct cellular distribution in the retina and in neurons they induce complex and sometimes opposing activities. Here, we show in anin vivotherapeutic model of glaucoma that a selective agonist of the pro‐survival TrkA receptor was effective at preventing RGC death. RGC loss was fully prevented by combining the selective agonist of TrkA with intraocular pressure‐lowering drugs. In contrast, neither NGF nor an antagonist of the pro‐apoptotic p75 receptor protected RGCs. These results further a neurotrophic rationale for glaucoma. © 2007 Wiley Periodicals, Inc. Develop Neurobiol, 2007.Keywords
This publication has 38 references indexed in Scilit:
- Differential actions of nerve growth factor receptors TrkA and p75NTR in a rat model of epileptogenesisMolecular and Cellular Neuroscience, 2005
- Long-Lasting Rescue of Age-Associated Deficits in Cognition and the CNS Cholinergic Phenotype by a Partial Agonist Peptidomimetic Ligand of TrkAJournal of Neuroscience, 2004
- Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertensionJournal of Neurobiology, 2004
- Small molecule and protein-based neurotrophic ligands: agonists and antagonists as therapeutic agentsExpert Opinion on Therapeutic Patents, 1999
- Physiology of the NeurotrophinsAnnual Review of Neuroscience, 1996
- Anterograde transport of neurotrophins and axodendritic transfer in the developing visual systemNature, 1996
- Small Peptide Mimics of Nerve Growth Factor Bind TrkA Receptors and Affect Biological ResponsesJournal of Biological Chemistry, 1995
- Long-term non-invasive measurement of intraocular pressure in the rat eyeCurrent Eye Research, 1995
- Neurotrophin signal transduction by the Trk receptorJournal of Neurobiology, 1994
- The Trk family of neurotrophin receptorsJournal of Neurobiology, 1994